NDLI: Hybrid biomaterial based on porous silica nanoparticles and Pluronic F-127 for sustained release of sildenafil: in vivo study on prostate cancer

Content Provider	Royal Society of Chemistry (RSC)
Author	Silveira, C. P. Durán, N. Apolinário, L. M. Paula, A. J. Fávaro, W. J.
Copyright Year	2015
Abstract	We describe here a drug depot hydrogel system comprising sildenafil (SIL; commercially available as Viagra®) incorporated in mesoporous silica nanoparticles (MSNs; around 60 nm of diameter) and conjugated with a thermosensitive poloxamer (Pluronic F-127 or PF127; possessing a liquid–gel transition over a determined temperature). The conjugation of these components results in an anticancer biomaterial with optimized physico-chemical properties: (i) MSNs are colloidally stabilized mainly through repulsive depletion forces manifested in PF127 concentrations above 5 wt%; (ii) the gelation temperature of the systems is set to about 20 °C (attained with 18 wt% of PF127) in order to result in prompt gelation when they are intraperitoneally administered (in rats) as liquids; (iii) and the hydrogel is able to induce a prolonged release of MSNs + SIL. After testing these new formulations against chemically induced prostate cancer in rats, the histopathological analyses of the prostate showed that the hybrid systems were able to largely reduce the prostate tumor level, and also highlighted the role of the MSNs in this process, since the improvement of the tumor condition was proportional to the nanoparticles concentration.
Starting Page	81348
Ending Page	81355
Page Count	8
File Format	HTM / HTML PDF
ISSN	20462069
Volume Number	5
Issue Number	99
Journal	RSC Advances
DOI	10.1039/c5ra15006j
Language	English
Publisher	Royal Society of Chemistry
Access Restriction	Open
Subject Keyword	Safety integrity level Mesoporous silica Poloxamer Biomaterial Sildenafil Prostate cancer Gel
Content Type	Text
Resource Type	Article
Subject	Chemistry Chemical Engineering

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Hybrid biomaterial based on porous silica nanoparticles and Pluronic F-127 for sustained release of sildenafil: in vivo study on prostate cancer

Protein sustained release from isobutyramide-grafted stellate mesoporous silica nanoparticles

Sustained-release study on Exenatide loaded into mesoporous silica nanoparticles: in vitro characterization and in vivo evaluation.

Effect of Pluronic Gels on the Rectal Absorption of Indomethacin in Rabbits

Antitumor Effect of Pluronic F-127 Gel Containing Mitomycin C on Sarcoma-180 Ascites Tumor in Mice

Sustained-release study on Exenatide loaded into mesoporous silica nanoparticles: in vitro characterization and in vivo evaluation

In Vivo Sustained Release of Peptide Vaccine Mediated by Dendritic Mesoporous Silica Nanocarriers

Liver cancer cells: targeting and prolonged-release drug carriers consisting of mesoporous silica nanoparticles and alginate microspheres

Encapsulation and Controlled Release of Resveratrol Within Functionalized Mesoporous Silica Nanoparticles for Prostate Cancer Therapy

Hybrid biomaterial based on porous silica nanoparticles and Pluronic F-127 for sustained release of sildenafil: in vivo study on prostate cancer

Similar Documents

Hybrid biomaterial based on porous silica nanoparticles and Pluronic F-127 for sustained release of sildenafil: in vivo study on prostate cancer

Protein sustained release from isobutyramide-grafted stellate mesoporous silica nanoparticles

Sustained-release study on Exenatide loaded into mesoporous silica nanoparticles: in vitro characterization and in vivo evaluation.

Effect of Pluronic Gels on the Rectal Absorption of Indomethacin in Rabbits

Antitumor Effect of Pluronic F-127 Gel Containing Mitomycin C on Sarcoma-180 Ascites Tumor in Mice

Sustained-release study on Exenatide loaded into mesoporous silica nanoparticles: in vitro characterization and in vivo evaluation

In Vivo Sustained Release of Peptide Vaccine Mediated by Dendritic Mesoporous Silica Nanocarriers

Liver cancer cells: targeting and prolonged-release drug carriers consisting of mesoporous silica nanoparticles and alginate microspheres

Encapsulation and Controlled Release of Resveratrol Within Functionalized Mesoporous Silica Nanoparticles for Prostate Cancer Therapy

Hybrid biomaterial based on porous silica nanoparticles and Pluronic F-127 for sustained release of sildenafil: in vivo study on prostate cancer